ISBN: 9783846557945 - first line therapy in multiple myeloma: overview of recent therapy in treatment of new multiple myeloma patients (10 Ergebnisse)

Zustand: New.

Taschenbuch. Zustand: Neu. First line therapy in Multiple Myeloma | Overview of recent therapy in treatment of new Multiple Myeloma patients | Ahmed Rabea | Taschenbuch | 140 S. | Englisch | 2011 | LAP LAMBERT Academic Publishing | EAN 9783846557945 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. …

Paperback. Zustand: Brand New. 140 pages. 8.66x5.91x0.32 inches. In Stock.

Paperback. Zustand: Brand New. 140 pages. 8.66x5.91x0.32 inches. In Stock.

Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In the past, survival in Multiple Myeloma was in the range of 1 to 3 years. With the introduction of the novel drugs as the immunomodulators (IMiDs) and Proteosome inhibitors, survival has markedly increased and quality of life has improved. In this book, I have given an overview of the novel drugs and their use as first line therapy in multiple myeloma aiming for better prognosis, survival and quality of life. 140 pp. Englisch.…

Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Rabea AhmedOncology Specialist, Assistant Lecturer of Medical Oncology, National Cancer Institite, Cairo University, Egypt. Clinical Fellow of Hemato-oncology, Princess Margaret Hospital, Toronto, Canada. Master Degree student in Adv.…

Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In the past, survival in Multiple Myeloma was in the range of 1 to 3 years. With the introduction of the novel drugs as the immunomodulators (IMiDs) and Proteosome inhibitors, survival has markedly increased and quality of life has improved. In this book, I have given an overview of the novel drugs and their use as first line therapy in multiple myeloma aiming for better prognosis, survival and quality of life.…

Zustand: New. Print on Demand.

Zustand: New. PRINT ON DEMAND.

Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In the past, survival in Multiple Myeloma was in the range of 1 to 3 years. With the introduction of the novel drugs as the immunomodulators (IMiDs) and Proteosome inhibitors, survival has markedly increased and quality of life has improved. In this book, I have given an overview of the novel drugs and their use as first line therapy in multiple myeloma aiming for better prognosis, survival and quality of life.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 140 pp. Englisch.…